Dear Dr. Rowland, Please accept our response to Dr. Frederick Guilford's comments of November 17, 2014, regarding our recent article which appeared in your Journal [1] .
The main issue described by Dr. Guilford refers to a published paper [2] referenced in the discussion section of our paper (reference #68). We cited that paper as an example of an in vitro study where intact GSH was shown to be more effective than N-acetylcysteine in "restoring immune function in macrophages from HIV-infected individuals" [1] . Indeed, Dr. Guilford is correct in that the GSH preparation used in that study was a liposome encapsulated GSH obtained from his company as opposed to the non-encapsulated form used in our study. However, I would like to emphasize that our study was not designed to test the relative efficacy of different GSH preparations, including liposomal GSH, but rather to determine the impact of GSH supplementation alone on GSH levels in blood and exfoliated buccal cells.
We disagree with Dr. Guilford's assertion that GSH must be broken down prior to absorption into cells. While mechanisms are still under study, numerous GSH transporters have been identified in mammalian cells [3, 4] . Further, direct absorption has been reported in human and rodent cells as wells as in mice in vivo [4, 5] . Liposomal This reply refers to the article available at doi:10.1007/s00394-015-0874-5.
